ETON - Latest News
Eton Pharmaceuticals, Inc. (ETON), operates in Healthcare / Drug Manufacturers - Specialty & Generic, trades on NASDAQ.
Market capitalization stands near $1.61B. Trailing twelve-month P/E ratio is 128.23. Beta to the broader market is 0.87.
The article list below shows the most recent ETON headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent ETON Headlines
Why Eton Pharmaceuticals Is Top of the Class Today
fool.com - Aug 14, 2026
Eton Pharmaceuticals beat on both top and bottom lines last night. Management is licensing a new drug, and raising guidance through the end of 2026.
Eton Pharmaceuticals: No Reason Pharma Can't Deliver More Great Earnings Like These
seekingalpha.com - Aug 14, 2026
Eton Pharmaceuticals, Inc. delivered record Q2 2026 results, with product sales up 99% and full-year revenue guidance raised to over $145 million.
Eton Pharmaceuticals, Inc. (ETON) Q2 2026 Earnings Call Transcript
seekingalpha.com - Aug 14, 2026
Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals Q2 Earnings Call Highlights
marketbeat.com - Aug 13, 2026
Eton Pharmaceuticals NASDAQ: ETON reported second-quarter revenue nearly doubled from a year earlier, driven by the relaunch of HEMANGEOL and growth a
Eton Pharmaceuticals, Inc. (ETON) Q2 Earnings and Revenues Beat Estimates
zacks.com - Aug 13, 2026
Eton Pharmaceuticals, Inc. (ETON) came out with quarterly earnings of $0.
How News Affects ETON Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ETON's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked ETON news questions
- What is the latest ETON news headline?
- The most recent ETON headline (Aug 14, 2026) is "Why Eton Pharmaceuticals Is Top of the Class Today". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the ETON news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What ETON news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual ETON options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.